Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

News Daily News

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

June 06, 2025

Questions Raised About Study Linking mRNA Vaccines to Increased ACS Risk

News Daily News

Questions Raised About Study Linking mRNA Vaccines to Increased ACS Risk

December 03, 2021

Use of Culprit vs Multivessel PCI for STEMI Tracks With Trial Results

News Daily News

Use of Culprit vs Multivessel PCI for STEMI Tracks With Trial Results

November 04, 2020

COVID-19 Linked to 38% Drop in US STEMIs

News Daily News

COVID-19 Linked to 38% Drop in US STEMIs

April 10, 2020

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

News Conference News CRT 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Michael O'Riordan

February 25, 2020

EXCEL Investigators Respond to Data Suppression Claims As Debate Erupts Online

News Features

EXCEL Investigators Respond to Data Suppression Claims as Debate Erupts Online

Michael O'Riordan

December 12, 2019

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2016

February 01, 2016

News Daily News

Complete Revascularization Reduces Mortality, MI, and Repeat Procedures in Multivessel CAD: Meta-Analysis

Michael O'Riordan

January 21, 2016

News Daily News

Former FDA Staffer Says Missing Data Across Antithrombotic Trials Cast Doubt on Drug Effects

January 18, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.